Home
>
US Stocks
>
Precigen Inc
Precigen Inc
PGEN

Precigen Inc (PGEN)

$4.580.22%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$4.6
Today Low/High$4.56 / $4.72
52 Week Low/High$3.95 / $11.1
P/E ratio-7.75
Market Cap$944.36M

Company Details

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. The Company's technologies enable to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
OrganisationPrecigen Inc
HeadquatersGermantown, Maryland, US
Employees194
IndustryHealth Technology
CEOHelen Sabzevari

Discover more

Frequently Asked Questions

What is Precigen Inc (PGEN) share price today?

Can Indians buy Precigen Inc (PGEN) shares?

How can I buy Precigen Inc (PGEN) shares from India?

Can Fractional shares of Precigen Inc (PGEN) be purchased?

What are the documents required to start investing in Precigen Inc (PGEN) stocks?

We are a SEBI registered investement advisor